Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
310 GBX | +0.65% | +3.33% | +9.54% |
Apr. 26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
Apr. 26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |